FINOTTI, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 10.674
EU - Europa 4.235
AS - Asia 3.052
SA - Sud America 61
OC - Oceania 28
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.079
Nazione #
US - Stati Uniti d'America 10.591
CN - Cina 1.551
IT - Italia 1.166
PL - Polonia 1.009
SG - Singapore 680
UA - Ucraina 514
DE - Germania 509
TR - Turchia 348
GB - Regno Unito 295
SE - Svezia 283
ID - Indonesia 178
FI - Finlandia 149
FR - Francia 95
HK - Hong Kong 79
CA - Canada 67
BR - Brasile 51
VN - Vietnam 47
IR - Iran 41
BE - Belgio 38
NL - Olanda 36
IN - India 35
CZ - Repubblica Ceca 25
RU - Federazione Russa 22
AU - Australia 21
GR - Grecia 20
RO - Romania 16
LT - Lituania 14
PK - Pakistan 13
JP - Giappone 12
EG - Egitto 11
MX - Messico 11
KR - Corea 10
CH - Svizzera 9
MY - Malesia 9
AT - Austria 8
ES - Italia 8
NZ - Nuova Zelanda 7
TW - Taiwan 7
IE - Irlanda 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
LY - Libia 5
SA - Arabia Saudita 5
TN - Tunisia 5
EC - Ecuador 4
PT - Portogallo 4
AR - Argentina 3
BD - Bangladesh 3
DM - Dominica 3
IQ - Iraq 3
PH - Filippine 3
ZA - Sudafrica 3
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BT - Bhutan 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 18.079
Città #
Woodbridge 1.127
Fairfield 1.122
Warsaw 1.006
Chandler 775
Ann Arbor 772
Ashburn 722
Santa Clara 716
Houston 662
Jacksonville 652
Singapore 536
Beijing 509
Wilmington 466
Seattle 445
Ferrara 393
Cambridge 339
Nanjing 246
Izmir 225
Princeton 199
Jakarta 163
Addison 130
Shanghai 130
Boardman 128
Bremen 111
New York 111
Bologna 106
Redwood City 93
Milan 91
San Diego 86
Shenyang 81
Hong Kong 70
Los Angeles 65
Nanchang 61
Falls Church 58
Munich 49
Hebei 48
Dong Ket 47
London 46
Dearborn 43
Changsha 38
Jiaxing 38
Jinan 34
Brussels 33
Mountain View 33
Auburn Hills 30
Norwalk 30
Toronto 27
Zhengzhou 27
Guangzhou 26
San Jose 25
Helsinki 24
Tianjin 23
Rome 22
Washington 22
Des Moines 21
Kunming 19
Brno 18
Ningbo 18
Parma 18
Verona 18
Ferrara di Monte Baldo 17
Hefei 17
Frankfurt am Main 16
Leawood 15
Hangzhou 14
Ottawa 14
Padova 14
Amsterdam 10
Chicago 10
Fars 10
Indiana 10
Montréal 10
Napoli 10
Catania 9
Lanzhou 9
Orange 9
Tappahannock 9
Changchun 8
Redmond 8
Chengdu 7
Fuzhou 7
Kilburn 7
Leiden 7
San Mateo 7
Taizhou 7
Delhi 6
Foggia 6
Hounslow 6
Paris 6
Philadelphia 6
Preganziol 6
Sydney 6
Taipei 6
Wuhan 6
Yogyakarta 6
Augusta 5
Basel 5
Cattolica 5
Genoa 5
Guarda Veneta 5
Modena 5
Totale 13.524
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 313
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 295
A validated cellular biobank for β-thalassemia 284
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 258
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 234
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 212
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 205
A validated THALAMOSS cellular biobank for β-thalassemia 197
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 183
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis 182
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 180
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 176
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 175
Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices 160
SPR-based non-invasive prenatal testing for fetal sex determination 159
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 153
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 152
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 149
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 144
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 143
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 143
null 142
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 141
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 138
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 138
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 135
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 135
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 134
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies 132
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 129
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 128
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 127
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 127
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 126
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 125
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 124
Regulation of IL-8 gene expression in gliomas by microRNAs 123
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 120
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 120
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 120
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 119
null 117
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 117
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 116
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 115
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 114
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 112
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 111
null 110
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 110
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 109
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development 109
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 109
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 108
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 108
AGENTI TRASFETTANTI PER ACIDI PEPTIDO-NUCLEICI 108
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 107
null 107
Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene 107
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 106
Involvement of miRNA in erythroid differentiation 104
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 104
Recent trends for novel options in experimental biological therapy of β-thalassemia 103
null 103
null 103
Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene 103
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 103
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 102
null 102
Impiego di strategie di microRNA targeting combinate a trattamenti con composti di origine naturale ad attività antiproliferativa e pro-apoptotica: studio dell’effetto antitumorale in-vitro su modelli cellulari di carcinoma del colon-retto, di glioblastoma e di carcinoma mammario (NaturalMiR-Combo)” 102
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 101
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 101
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 101
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 101
null 99
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA) 97
null 96
Recent trends in the gene therapy of β-thalassemia 93
Non-invasive Prenatal Testing Using Fetal DNA 93
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 92
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 92
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 90
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 89
Development of microRNA based protocols for detection of autologous blood transfusion in sport 89
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 88
Alteration of microRNA biological activity with peptide nucleic acid 88
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 86
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 86
Development and molecular characterization of transgenic mice for beta-thalassemia 85
null 85
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle 85
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 83
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) 82
Expression of miR-93 and IL-8 During Pseudomonas aeruginosa Mediated Induction of Pro-Inflammatory Responses 81
Invitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells 81
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 80
In vitro evaluation of the biological activity of Lebanese medicinal plants extracts against herpes simplex virus type 1 80
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 79
SPR-based identification of microRNAs 79
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 78
Totale 12.469
Categoria #
all - tutte 94.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.511
Totale 97.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.853 0 0 0 0 0 313 260 286 322 395 186 91
2020/20213.158 164 143 140 195 198 295 283 313 139 480 514 294
2021/20222.113 226 179 129 93 138 107 141 96 95 170 182 557
2022/20231.959 230 191 41 240 322 224 125 179 205 16 106 80
2023/20241.494 84 182 63 42 188 251 121 86 24 28 75 350
2024/20252.145 181 152 495 289 598 430 0 0 0 0 0 0
Totale 18.671